Molina Healthcare (MOH)
Market Price (12/25/2025): $163.25 | Market Cap: $8.6 BilSector: Health Care | Industry: Managed Health Care
Molina Healthcare (MOH)
Market Price (12/25/2025): $163.25Market Cap: $8.6 BilSector: Health CareIndustry: Managed Health Care
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 10%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.1% | Weak multi-year price returns2Y Excs Rtn is -101%, 3Y Excs Rtn is -132% | Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.0%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.3% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -54% | Key risksMOH key risks include [1] its extreme reliance on government-funded programs, Show more. | |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -48% | ||
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Health Data Analytics, Telehealth Platforms, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 10%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.1% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -54% |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -48% |
| Megatrend and thematic driversMegatrends include Digital Health & Telemedicine, and Aging Population & Chronic Disease. Themes include Health Data Analytics, Telehealth Platforms, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -101%, 3Y Excs Rtn is -132% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -1.0%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -1.3% |
| Key risksMOH key risks include [1] its extreme reliance on government-funded programs, Show more. |
Why The Stock Moved
Qualitative Assessment
AI Analysis | Feedback
1. Challenging Medical Cost Environment and Reduced Earnings Guidance. Molina Healthcare reported a very challenging medical cost environment in the third quarter of 2025, resulting in a consolidated Medical Care Ratio (MCR) of 92.6%, which fell below expectations. This led to a revision of the full-year 2025 adjusted earnings per share (EPS) guidance to approximately $14 per share, a $5 reduction from the previous guidance of $19 per share.2. Increased Utilization and Persistent Medical Cost Trends. The company experienced sustained higher utilization, particularly among its high-acuity Medicare-Medicaid Plan (MMP) membership, alongside increases in both inpatient and outpatient utilization. These medical cost increases were described as unprecedented in their magnitude and persistence, exceeding the rate updates received and largely depleting risk corridor protections by the first and second quarters of 2025.
Show more
Stock Movement Drivers
Fundamental Drivers
The -14.3% change in MOH stock from 9/24/2025 to 12/24/2025 was primarily driven by a -23.9% change in the company's Net Income Margin (%).| 9242025 | 12242025 | Change | |
|---|---|---|---|
| Stock Price ($) | 190.71 | 163.47 | -14.28% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 43413.00 | 44550.00 | 2.62% |
| Net Income Margin (%) | 2.60% | 1.98% | -23.85% |
| P/E Multiple | 9.05 | 9.72 | 7.44% |
| Shares Outstanding (Mil) | 53.60 | 52.50 | 2.05% |
| Cumulative Contribution | -14.32% |
Market Drivers
9/24/2025 to 12/24/2025| Return | Correlation | |
|---|---|---|
| MOH | -14.3% | |
| Market (SPY) | 4.4% | 10.6% |
| Sector (XLV) | 14.2% | 22.8% |
Fundamental Drivers
The -44.4% change in MOH stock from 6/25/2025 to 12/24/2025 was primarily driven by a -29.4% change in the company's Net Income Margin (%).| 6252025 | 12242025 | Change | |
|---|---|---|---|
| Stock Price ($) | 294.14 | 163.47 | -44.42% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 41866.00 | 44550.00 | 6.41% |
| Net Income Margin (%) | 2.81% | 1.98% | -29.44% |
| P/E Multiple | 13.66 | 9.72 | -28.83% |
| Shares Outstanding (Mil) | 54.60 | 52.50 | 3.85% |
| Cumulative Contribution | -44.51% |
Market Drivers
6/25/2025 to 12/24/2025| Return | Correlation | |
|---|---|---|
| MOH | -44.4% | |
| Market (SPY) | 14.0% | 6.8% |
| Sector (XLV) | 16.9% | 36.2% |
Fundamental Drivers
The -44.6% change in MOH stock from 12/24/2024 to 12/24/2025 was primarily driven by a -34.6% change in the company's P/E Multiple.| 12242024 | 12242025 | Change | |
|---|---|---|---|
| Stock Price ($) | 295.19 | 163.47 | -44.62% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 39199.00 | 44550.00 | 13.65% |
| Net Income Margin (%) | 2.92% | 1.98% | -32.09% |
| P/E Multiple | 14.86 | 9.72 | -34.61% |
| Shares Outstanding (Mil) | 57.60 | 52.50 | 8.85% |
| Cumulative Contribution | -45.06% |
Market Drivers
12/24/2024 to 12/24/2025| Return | Correlation | |
|---|---|---|
| MOH | -44.6% | |
| Market (SPY) | 15.8% | 6.0% |
| Sector (XLV) | 13.3% | 38.3% |
Fundamental Drivers
The -51.2% change in MOH stock from 12/25/2022 to 12/24/2025 was primarily driven by a -57.7% change in the company's P/E Multiple.| 12252022 | 12242025 | Change | |
|---|---|---|---|
| Stock Price ($) | 335.08 | 163.47 | -51.21% |
| Change Contribution By | LTM | LTM | |
| Total Revenues ($ Mil) | 31160.00 | 44550.00 | 42.97% |
| Net Income Margin (%) | 2.69% | 1.98% | -26.39% |
| P/E Multiple | 23.00 | 9.72 | -57.75% |
| Shares Outstanding (Mil) | 57.60 | 52.50 | 8.85% |
| Cumulative Contribution | -51.60% |
Market Drivers
12/25/2023 to 12/24/2025| Return | Correlation | |
|---|---|---|
| MOH | -54.4% | |
| Market (SPY) | 48.9% | 6.1% |
| Sector (XLV) | 18.8% | 34.9% |
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MOH Return | 57% | 50% | 4% | 9% | -19% | -44% | 21% |
| Peers Return | 6% | 39% | 4% | -8% | -25% | 2% | 9% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 18% | 115% |
Monthly Win Rates [3] | |||||||
| MOH Win Rate | 67% | 75% | 42% | 58% | 33% | 42% | |
| Peers Win Rate | 50% | 53% | 52% | 42% | 45% | 55% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| MOH Max Drawdown | -21% | -5% | -21% | -21% | -24% | -54% | |
| Peers Max Drawdown | -35% | -6% | -13% | -21% | -30% | -30% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: CNC, UNH, ELV, CVS, HUM. See MOH Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/24/2025 (YTD)
How Low Can It Go
| Event | MOH | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -29.4% | -25.4% |
| % Gain to Breakeven | 41.7% | 34.1% |
| Time to Breakeven | 272 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -29.9% | -33.9% |
| % Gain to Breakeven | 42.7% | 51.3% |
| Time to Breakeven | 16 days | 148 days |
| 2018 Correction | ||
| % Loss | -30.8% | -19.8% |
| % Gain to Breakeven | 44.5% | 24.7% |
| Time to Breakeven | 194 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -59.0% | -56.8% |
| % Gain to Breakeven | 143.8% | 131.3% |
| Time to Breakeven | 843 days | 1,480 days |
Compare to UNH, ELV, CI, HUM, CNC
In The Past
Molina Healthcare's stock fell -29.4% during the 2022 Inflation Shock from a high on 10/26/2022. A -29.4% loss requires a 41.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
AI Analysis | Feedback
- UnitedHealth Group, but specialized in government-funded healthcare programs like Medicaid and Medicare.
- An insurance company like Elevance Health (formerly Anthem), but primarily serving beneficiaries of Medicaid and Medicare plans.
AI Analysis | Feedback
- Medicaid Managed Care: Provides comprehensive health insurance coverage and services to low-income individuals and families through state Medicaid programs.
- Medicare Advantage: Offers health plans for eligible seniors and individuals with disabilities, covering medical and prescription drug benefits.
- Marketplace Health Plans (Affordable Care Act): Delivers subsidized health insurance coverage and services to individuals and families via state and federal health insurance marketplaces.
- Integrated Dual Eligible Plans: Manages coordinated health and long-term care benefits for individuals who qualify for both Medicaid and Medicare.
AI Analysis | Feedback
Molina Healthcare (MOH) primarily serves individuals through government-sponsored healthcare programs and health insurance marketplaces. Its major customer categories are:
- Medicaid Members: Individuals and families who qualify for state-sponsored Medicaid programs. Molina contracts with various state governments to provide managed care services to these low-income populations.
- Medicare Members: Seniors and individuals with disabilities enrolled in Molina's Medicare Advantage plans (Medicare Part C) and Medicare Prescription Drug Plans (Medicare Part D).
- Health Insurance Marketplace Members: Individuals and families who purchase health insurance plans through the Affordable Care Act (ACA) exchanges (also known as the public health insurance marketplaces).
AI Analysis | Feedback
AI Analysis | Feedback
Joseph Zubretsky President and Chief Executive Officer
Joseph Zubretsky has over 35 years of experience in the insurance and financial services sectors. Prior to joining Molina Healthcare as President and CEO in 2017, he served as President and Chief Executive Officer for The Hanover Insurance Group from June 2016 to October 2017. Before that, he held several senior executive roles at Aetna for nearly nine years, including Chief Executive Officer of its Healthagen Holdings subsidiary, Senior Executive Vice President of National Businesses, and Executive Vice President and Chief Financial Officer from 2007 to 2013. He began his career at Coopers & Lybrand as a partner in its national insurance practice. Zubretsky was also a partner at Brera Capital Partners, a global private equity firm, and held executive positions at Unum Group and MassMutual Financial Group.
Mark Keim Senior Executive Vice President and Chief Financial Officer
Mark Keim joined Molina Healthcare in January 2018 and was appointed Chief Financial Officer in February 2021. He has decades of experience in managed care and financial services. Previously, he served as Global Head of Strategy and Corporate Development at Aetna and Executive Vice President of Corporate Development and Strategy at The Hanover Insurance Group, where he worked alongside Joseph Zubretsky. Keim also had an accomplished career at GE Capital. In September 2024, his role was expanded to include leadership of the Company's Medicaid Health Plans and Marketplace business.
James Woys Executive Vice President, Health Plan Services
James Woys serves as the Executive Vice President, Health Plan Services at Molina Healthcare.
Jeff Barlow Chief Legal Officer and Corporate Secretary
Jeff Barlow serves as the Chief Legal Officer and Corporate Secretary for Molina Healthcare.
Lawrence Anderson EVP, Chief Human Resources Officer
Lawrence Anderson holds the position of Executive Vice President, Chief Human Resources Officer at Molina Healthcare.
AI Analysis | Feedback
Molina Healthcare (MOH) faces several key risks to its business, primarily due to its heavy reliance on government-sponsored healthcare programs and the inherent challenges in managing healthcare costs.
Reliance on Government Programs and Regulatory/Policy Changes
Molina Healthcare's business model is heavily dependent on government-sponsored healthcare programs, including Medicaid, Medicare, and those under the Affordable Care Act (ACA). Consequently, the company is highly susceptible to political uncertainty and potential shifts in healthcare policies. Changes in government funding mechanisms, eligibility criteria for beneficiaries, or program structures, especially concerning Medicaid, could significantly impact Molina's operations and financial performance. A projected $880 billion cut to the Medicaid budget in the coming years is identified as a primary risk for Molina Healthcare, given that approximately 88.35% of its subscribers were enrolled in Medicaid in 2024.
Medical Cost Management and Medical Loss Ratio (MLR) Pressures
A significant risk for Molina Healthcare is its ability to accurately predict and effectively manage medical care costs. The company has experienced ongoing pressure on its Medical Loss Ratio (MLR) across all segments, indicating challenges in controlling healthcare expenses. For example, Molina reported a 170 basis point miss on MLR in the fourth quarter of 2024, contributing to disappointing financial results and downward revisions of its earnings guidance. Furthermore, the company is facing investigations and securities class action lawsuits alleging inadequate disclosure of adverse developments in medical cost trends and discrepancies between premium rates and medical expenses.
Competition and Contract Retention
The healthcare sector is characterized by increasing competition and consolidation, posing a risk to Molina Healthcare's ability to maintain and expand its customer base. To remain competitive, Molina must continuously innovate and offer compelling services. The potential loss of significant state Medicaid contracts could have a material adverse effect on the company's business, financial condition, cash flows, and results of operations.
AI Analysis | Feedback
null
AI Analysis | Feedback
Molina Healthcare (MOH) primarily operates in the U.S. government-sponsored healthcare programs, with its main products and services focused on Medicaid, Medicare, and Health Insurance Marketplace plans. The addressable markets for these services in the U.S. are as follows:
-
Medicaid (U.S.): The total enrollment in the Medicaid program in the U.S. was approximately 79.15 million beneficiaries in December 2024. Total Medicaid expenditures in the U.S. were $900.3 billion in the 2023 fiscal year.
-
Medicare (U.S.): The U.S. Medicare-eligible population is projected to reach 73.2 million individuals as of 2024. The Medicare Advantage market penetration was 48.2% in 2024.
-
Health Insurance Marketplace (ACA) (U.S.): Null
AI Analysis | Feedback
Molina Healthcare (MOH) is anticipated to drive future revenue growth over the next 2-3 years through a combination of strategic initiatives and market expansions:
-
Strategic Acquisitions: Molina Healthcare has a history of executing strategic acquisitions that significantly contribute to its premium revenue and expand its member base. Recent examples include the acquisition of ConnectiCare in February 2025, projected to add approximately $1.4 billion in annual premium revenue and about 140,000 members, and the acquisition of Bright Health's Medicare Advantage business in California in January 2024, which added 109,000 members.
-
Expansion in Government Contracts and Dual Special Needs Plans (D-SNPs): The company is actively securing new government contracts across various states, such as Michigan, Massachusetts, Nevada, Illinois, Georgia, and Texas. These contract wins are expected to drive substantial premium revenue by 2027. Furthermore, Molina plans to increase its presence in Dual Special Needs Plans (D-SNP) markets by 23% for 2025, aligning with CMS rules aimed at streamlining care for dual-eligible individuals, which is expected to boost both membership and revenue.
-
Membership Growth in Core Government Programs: Molina anticipates significant membership growth in its core government-sponsored programs, including Medicaid and Medicare Advantage. The company projects its Medicaid membership to reach 5.1 million people by the end of 2025, with ACA and Medicare enrollment also expected to grow to 580,000 and 250,000 members, respectively, by the close of 2025. This growth is a direct result of strategic acquisitions and new contract wins.
-
Strategic Management of the Marketplace Segment: While facing utilization pressures, Molina is strategically managing its Marketplace business to ensure profitable growth. The company plans to materially reprice and reduce its Marketplace exposure, with rate increases averaging 30% and a 20% reduction in county coverage, to create a smaller, more profitable segment.
AI Analysis | Feedback
Share Repurchases
- Molina Healthcare announced a share repurchase program of up to $1,000 million in April 2025, valid until December 31, 2026.
- The company executed $1 billion in share repurchases so far in 2025.
- Annual share buybacks for Molina Healthcare were $1 billion in 2024 and $400 million in 2022.
Share Issuance
- Molina Healthcare's shares outstanding decreased from 59.3 million in 2020 to 54 million in October 2025, indicating a net reduction due to repurchases rather than significant issuance.
Outbound Investments
- Molina Healthcare acquired ConnectiCare for $350 million in July 2024 (closed February 2025), adding approximately 140,000 members.
- In September 2020, Molina Healthcare acquired substantially all the assets of Affinity Health Plan for approximately $380 million, to deepen its service offerings in New York.
- Molina Healthcare made other acquisitions in 2021, including the Magellan Complete Care line of business from Magellan Health, Inc. and Cigna's Medicaid contracts in Texas.
Capital Expenditures
- Molina Healthcare invested $100 million in property, plant, and equipment in 2024, following $84 million in 2023.
- The company's regular capital expenditures range between $10 million to $35 million quarterly, reflecting ongoing investments in operations.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to MOH. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 21.1% | 21.1% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -6.7% | -6.7% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 16.7% | 16.7% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 2.3% | 2.3% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 11.8% | 11.8% | -5.1% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Molina Healthcare
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 211.36 |
| Mkt Cap | 53.9 |
| Rev LTM | 190,338 |
| Op Inc LTM | 6,037 |
| FCF LTM | 3,562 |
| FCF 3Y Avg | 3,656 |
| CFO LTM | 4,488 |
| CFO 3Y Avg | 4,640 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 11.2% |
| Rev Chg 3Y Avg | 10.5% |
| Rev Chg Q | 11.7% |
| QoQ Delta Rev Chg LTM | 2.8% |
| Op Mgn LTM | 2.8% |
| Op Mgn 3Y Avg | 3.6% |
| QoQ Delta Op Mgn LTM | -0.7% |
| CFO/Rev LTM | 2.2% |
| CFO/Rev 3Y Avg | 2.4% |
| FCF/Rev LTM | 1.7% |
| FCF/Rev 3Y Avg | 1.8% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 53.9 |
| P/S | 0.3 |
| P/EBIT | 10.2 |
| P/E | 15.4 |
| P/CFO | 12.6 |
| Total Yield | 7.0% |
| Dividend Yield | 1.7% |
| FCF Yield 3Y Avg | 4.6% |
| D/E | 0.4 |
| Net D/E | -0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 4.6% |
| 3M Rtn | 1.7% |
| 6M Rtn | 1.1% |
| 12M Rtn | -19.9% |
| 3Y Rtn | -41.4% |
| 1M Excs Rtn | 1.2% |
| 3M Excs Rtn | -0.6% |
| 6M Excs Rtn | -12.0% |
| 12M Excs Rtn | -35.5% |
| 3Y Excs Rtn | -122.1% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Medicaid | 26,327 | 25,783 | 21,231 | 15,217 | |
| Medicare | 4,179 | 3,824 | 3,379 | 2,529 | |
| Marketplace | 2,023 | 2,296 | 3,091 | 1,677 | |
| Other operating revenues | 1,467 | ||||
| Other | 76 | 71 | 70 | 14 | |
| Health Plans | 16,815 | ||||
| Total | 34,072 | 31,974 | 27,771 | 19,423 | 16,829 |
| $ Mil | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Medicaid | 2,973 | 2,981 | 2,322 | ||
| Other operating revenues | 1,467 | 1,020 | 846 | ||
| Marketplace | 499 | 290 | 399 | ||
| Medicare | 388 | 437 | 430 | ||
| Other | 9 | 11 | 14 | ||
| Other operating expenses | -3,763 | -3,566 | -2,991 | ||
| Total | 1,573 | 1,173 | 1,020 |
Price Behavior
| Market Price | $163.47 | |
| Market Cap ($ Bil) | 8.6 | |
| First Trading Date | 07/02/2003 | |
| Distance from 52W High | -53.7% | |
| 50 Days | 200 Days | |
| DMA Price | $157.30 | $228.05 |
| DMA Trend | down | down |
| Distance from DMA | 3.9% | -28.3% |
| 3M | 1YR | |
| Volatility | 49.6% | 52.5% |
| Downside Capture | 68.93 | 25.26 |
| Upside Capture | -17.19 | -37.21 |
| Correlation (SPY) | 9.2% | 5.9% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.08 | 0.38 | 0.30 | 0.27 | 0.14 | 0.29 |
| Up Beta | -0.53 | 0.04 | -0.08 | 1.43 | 0.54 | 0.50 |
| Down Beta | 1.08 | 1.52 | 1.37 | 0.82 | -0.17 | 0.07 |
| Up Capture | -9% | -92% | -57% | -85% | -21% | 1% |
| Bmk +ve Days | 12 | 25 | 38 | 73 | 141 | 426 |
| Stock +ve Days | 9 | 19 | 31 | 58 | 124 | 378 |
| Down Capture | 17% | 72% | 38% | 65% | 37% | 70% |
| Bmk -ve Days | 7 | 16 | 24 | 52 | 107 | 323 |
| Stock -ve Days | 10 | 22 | 31 | 66 | 123 | 371 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Comparison of MOH With Other Asset Classes (Last 1Y) | |||||||
|---|---|---|---|---|---|---|---|
| MOH | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -44.3% | 16.4% | 19.2% | 71.9% | 8.9% | 6.0% | -10.4% |
| Annualized Volatility | 52.2% | 17.3% | 19.5% | 19.3% | 15.3% | 17.1% | 35.0% |
| Sharpe Ratio | -0.92 | 0.72 | 0.78 | 2.69 | 0.36 | 0.18 | -0.12 |
| Correlation With Other Assets | 38.3% | 6.1% | -9.6% | -13.8% | 20.9% | 3.6% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Comparison of MOH With Other Asset Classes (Last 5Y) | |||||||
|---|---|---|---|---|---|---|---|
| MOH | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | -4.0% | 8.6% | 14.9% | 18.7% | 11.7% | 4.8% | 32.6% |
| Annualized Volatility | 36.4% | 14.5% | 17.1% | 15.5% | 18.7% | 18.9% | 48.7% |
| Sharpe Ratio | -0.02 | 0.41 | 0.70 | 0.97 | 0.51 | 0.17 | 0.59 |
| Correlation With Other Assets | 43.6% | 21.3% | -1.7% | 1.3% | 24.4% | 7.5% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Comparison of MOH With Other Asset Classes (Last 10Y) | |||||||
|---|---|---|---|---|---|---|---|
| MOH | Sector ETF | Equity | Gold | Commodities | Real Estate | Bitcoin | |
| Annualized Return | 10.7% | 9.8% | 14.7% | 14.9% | 6.9% | 5.2% | 69.2% |
| Annualized Volatility | 39.7% | 16.6% | 18.0% | 14.8% | 17.6% | 20.8% | 55.8% |
| Sharpe Ratio | 0.39 | 0.48 | 0.70 | 0.83 | 0.31 | 0.22 | 0.90 |
| Correlation With Other Assets | 48.5% | 34.7% | -1.6% | 10.4% | 32.1% | 4.8% | |
ETFs used for asset classes: Sector ETF = XLV, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 10/22/2025 | -17.5% | -17.9% | -31.1% |
| 7/7/2025 | -2.7% | -7.3% | -33.8% |
| 4/23/2025 | -5.5% | -1.5% | -6.7% |
| 2/5/2025 | -10.1% | -15.9% | 3.3% |
| 10/23/2024 | 17.7% | 17.9% | 7.7% |
| 7/24/2024 | 12.3% | 18.2% | 19.1% |
| 4/24/2024 | -4.1% | -7.8% | -7.2% |
| 2/7/2024 | 5.4% | 10.5% | 8.4% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 10 | 15 | 15 |
| # Negative | 15 | 10 | 10 |
| Median Positive | 5.5% | 7.3% | 7.1% |
| Median Negative | -2.7% | -4.7% | -7.4% |
| Max Positive | 17.7% | 18.2% | 19.1% |
| Max Negative | -17.5% | -17.9% | -33.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 10232025 | 10-Q 9/30/2025 |
| 6302025 | 7242025 | 10-Q 6/30/2025 |
| 3312025 | 4242025 | 10-Q 3/31/2025 |
| 12312024 | 2112025 | 10-K 12/31/2024 |
| 9302024 | 10242024 | 10-Q 9/30/2024 |
| 6302024 | 7252024 | 10-Q 6/30/2024 |
| 3312024 | 4252024 | 10-Q 3/31/2024 |
| 12312023 | 2132024 | 10-K 12/31/2023 |
| 9302023 | 10262023 | 10-Q 9/30/2023 |
| 6302023 | 7272023 | 10-Q 6/30/2023 |
| 3312023 | 4272023 | 10-Q 3/31/2023 |
| 12312022 | 2132023 | 10-K 12/31/2022 |
| 9302022 | 10272022 | 10-Q 9/30/2022 |
| 6302022 | 7282022 | 10-Q 6/30/2022 |
| 3312022 | 4282022 | 10-Q 3/31/2022 |
| 12312021 | 2142022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.